Michael Kalb
Finanzdirektor/CFO bei CATALYST PHARMACEUTICALS, INC.
Profil
Michael W.
Kalb is currently the Chief Financial Officer & Executive Vice President at Catalyst Pharmaceuticals, Inc. He previously held positions as the Director-Accounting & Financial Consulting Group at Huron Consulting Group, Inc., Chief Financial Officer & Senior Vice President at Amarin Corp.
Plc, Chief Financial & Accounting Officer, Group VP at Taro Pharmaceutical Industries Ltd., Chief Financial Officer at Ipi Legacy Liquidation Co., Chief Financial Officer at Taro Pharmaceuticals U.S.A., Inc., and Executive VP, Chief Financial & Accounting Officer at CinCor Pharma, Inc. He obtained his undergraduate degree from the State University of New York at Albany.
Aktive Positionen von Michael Kalb
| Unternehmen | Position | Beginn |
|---|---|---|
| CATALYST PHARMACEUTICALS, INC. | Finanzdirektor/CFO | 01.01.2024 |
Ehemalige bekannte Positionen von Michael Kalb
| Unternehmen | Position | Ende |
|---|---|---|
| IPI LEGACY LIQUIDATION CO | Finanzdirektor/CFO | 31.12.2023 |
| CINCOR PHARMA, INC. | Finanzdirektor/CFO | 01.03.2023 |
| AMARIN CORPORATION PLC | Finanzdirektor/CFO | 20.06.2022 |
| TARO PHARMACEUTICAL INDUSTRIES LTD. | Finanzdirektor/CFO | 29.06.2016 |
| HURON CONSULTING GROUP INC. | Comptroller/Controller/Auditor | - |
Ausbildung von Michael Kalb
| State University of New York at Albany | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 5 |
|---|---|
| TARO PHARMACEUTICAL INDUSTRIES LTD. | Health Technology |
| AMARIN CORPORATION PLC | Health Technology |
| HURON CONSULTING GROUP INC. | Commercial Services |
| IPI LEGACY LIQUIDATION CO | Health Technology |
| CATALYST PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Taro Pharmaceuticals U.S.A., Inc.
 Taro Pharmaceuticals U.S.A., Inc. Pharmaceuticals: GenericHealth Technology Part of Sun Pharmaceutical Industries Ltd., Taro Pharmaceuticals U.S.A., Inc. is a company that manufactures and sells generic pharmaceutical products. The company is based in Hawthorne, NY. | Health Technology |
CinCor Pharma, Inc.
 CinCor Pharma, Inc. Pharmaceuticals: MajorHealth Technology CinCor Pharma, Inc. operates as a clinical-stage biopharmaceutical company focused on developing its clinical candidate, CIN-107, for the treatment of hypertension and other cardio-renal diseases. The firm is developing CIN-107 for the treatment of multiple diseases where aldosterone plays a significant role in disease pathophysiology, including hypertension and primary aldosteronism, as well as its utility in ameliorating complications of chronic kidney disease. The company was founded by Jon Isaacsohn and Catherine Pearce on March 28, 2018 and is headquartered in Waltham, MA. | Health Technology |
